Effect of Jalaukavacharana in the management of Vatrakta

A clinical study to evaluate role of Jalaukavcharan in the management of Vatrakta - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054036

Enrollment

Registered

2023-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M100- Idiopathic gout

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical symptoms of vatrakta 2. Patient having elevated serum uric acid more than 8mg/dl 3. Age group of 20â??60 years. 4. Patients of either gender. 5. Patient with normal bleeding time(2-7 Minutes) and clotting time(8-15 Minutes)

Exclusion criteria

Exclusion criteria: 1. Patients having any other systemic illness like diabetes mellitus, hypothyroidism, rheumatoid arthritis. 2. Patient having any other systemic diseases such as paralysis, Parkinson's disease, severe anemia and cancer patients etc. 3. Pregnant ladies.

Design outcomes

Primary

Measure	Time frame
change in scoring pattern of VAS (visual analogue scale)Timepoint: 21days	—

Secondary

Measure	Time frame
Change in scoring pattern of VAS(Visual analouge scale) of Pain,Swelling,Tenderness,Burning sensationTimepoint: 21days	—

Countries

India

Contacts

Public ContactProf Sunil Kumar

National institute of Ayurveda,Jaipur

drsunilkumarbhu@gmail.com9414077592

Outcome results